Swiss National Bank trimmed its holdings in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 3.3% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 74,100 shares of the semiconductor company’s stock after selling 2,500 shares during the period. Swiss National Bank’s holdings in Axcelis Technologies were worth $2,995,000 as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. US Bancorp DE acquired a new stake in Axcelis Technologies during the 2nd quarter valued at $31,000. Captrust Financial Advisors boosted its position in Axcelis Technologies by 153.8% in the 1st quarter. Captrust Financial Advisors now owns 1,721 shares of the semiconductor company’s stock valued at $71,000 after buying an additional 1,043 shares during the last quarter. USA Financial Portformulas Corp bought a new position in Axcelis Technologies in the 2nd quarter valued at $104,000. Mutual of America Capital Management LLC boosted its position in Axcelis Technologies by 7.7% in the 1st quarter. Mutual of America Capital Management LLC now owns 4,505 shares of the semiconductor company’s stock valued at $185,000 after buying an additional 321 shares during the last quarter. Finally, Amalgamated Bank bought a new position in Axcelis Technologies in the 1st quarter valued at $200,000. 86.03% of the stock is owned by hedge funds and other institutional investors.
NASDAQ:ACLS opened at $48.47 on Thursday. Axcelis Technologies, Inc. has a 12-month low of $21.27 and a 12-month high of $52.80. The company has a quick ratio of 3.02, a current ratio of 4.83 and a debt-to-equity ratio of 0.09. The firm has a market capitalization of $1.63 billion, a P/E ratio of 27.23 and a beta of 1.44. The stock’s fifty day simple moving average is $44.02 and its 200-day simple moving average is $41.82.
A number of research analysts have commented on the company. Zacks Investment Research lowered Axcelis Technologies from a “buy” rating to a “hold” rating in a research report on Wednesday. B. Riley increased their price objective on Axcelis Technologies from $62.00 to $65.00 and gave the company a “buy” rating in a research report on Friday, August 6th.
In other Axcelis Technologies news, Director Dennis Thomas St sold 3,500 shares of Axcelis Technologies stock in a transaction dated Monday, August 30th. The stock was sold at an average price of $50.32, for a total transaction of $176,120.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Joseph P. Keithley sold 5,000 shares of Axcelis Technologies stock in a transaction dated Thursday, August 26th. The stock was sold at an average price of $48.49, for a total value of $242,450.00. The disclosure for this sale can be found here. Insiders sold a total of 41,596 shares of company stock worth $2,010,515 over the last 90 days. 2.11% of the stock is owned by corporate insiders.
Axcelis Technologies Profile
Axcelis Technologies, Inc engages in the manufacture of capital equipment for the semiconductor chip manufacturing industry. It ion implantation systems product line includes high current, medium current, and high energy implanters. It also offers post-sales equipment service and support, such as spare parts, equipment upgrades, used equipment, maintenance services, and customer training.
Recommended Story: Basic Economics creates winners and losers
Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLS).
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.